Navigation Links
Brigham and Women's Hospital researcher named National Space Biomedical Research Institute Fellow
Date:3/3/2011

Boston, MA - Christopher J. Morris, PhD, of the Division of Sleep Medicine at Brigham and Women's Hospital, is one of four scientists selected by the National Space Biomedical Research Institute (NSBRI) for a postdoctoral fellowship.

"NSBRI has added some of the brightest young scientists the United States has to offer. These new fellows will have a role in the Institute's efforts to protect astronaut health and to improve health care on Earth," said Dr. Jeffrey P. Sutton, NSBRI director.

The two-year program offers fellows the opportunity to manage their own space-related biomedical research project while continuing to learn from an experienced faculty mentor. Dr. Morris is working with mentor Frank A.J.L. Scheer, PhD, Assistant Professor of Medicine at Harvard Medical School and at the Division of Sleep Medicine at BWH, to look at the effects of sudden shifts in sleep/wake patterns (slam shifts), typical for astronauts, on the cardiovascular system.

"The great benefit of the work we're doing is that it could have implications for both astronauts and members of the general public," said Dr. Morris. "The results of this study may furthermore shed light on the physiological mechanisms underlying the increased risk for the development of cardiovascular disease, obesity and diabetes in shift workers," added Dr. Scheer.

Dr. Morris, under highly controlled laboratory conditions, will measure the response of various cardiovascular parameters to three consecutive periods of simulated day and night work. Such an experimental design will enable Dr. Morris to determine the direct effect of a single simulated slam shift on cardiovascular indices. Moreover, the experiment will determine if the immediate effect of a single slam shift on cardiovascular measures are sustained, exacerbated or removed following repeated exposures to slam shift work. Dr. Morris will compare cardiovascular responses in day workers and night shift workers to de
'/>"/>

Contact: Holly Brown-Ayers
hbrown-ayers@partners.org
617-534-1603
Brigham and Women's Hospital
Source:Eurekalert

Page: 1 2

Related biology news :

1. Brown University and Women & Infants Hospital expand national childrens study to Bristol County
2. Field-hospital-on-a-chip project awarded to nanoengineer from UC San Diego
3. First results from hospital trials testing
4. Rhode Island Hospital simulation center examines benefits and applications of medical simulation
5. Childrens Hospital scientists achieve repair of injured heart muscle in lab tests of stem cells
6. International copper industry defines role in the fight against hospital infections
7. Mount Sinai Hospital researcher makes stem cell breakthrough
8. Research could lead to new non-antibiotic drugs to counter hospital infections
9. Childrens Hospital Oakland is first pediatric hospital to use laboratory-on-a-card technology
10. Childrens Hospital Oakland scientists first to discover new source for harvesting stem cells
11. Childrens Hospital of Pittsburgh of UPMC scientists identify enzyme important in aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2015)... Feb. 24, 2015 Research and Markets ... of the "Global 2D Gesture Recognition Market ... The analysts forecast the Global 2D Gesture ... 32.12% over the period 2014-2019 The ... sectors is one of the major trends in ...
(Date:2/19/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/kx9zp8/military ) ... Electro-Optical / Infrared Systems Market by Type, by ... to 2020" report to their offering. ... expected to reach $16.35 billion by 2020, to ... report segments the military electro-optical/infrared systems market on ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT Genomics ... that aims to transform cancer genomic information into ... the company has raised US$ 8 million in the ... in Taipei, Taiwan , ACT ... ACTOnco™. With the aim to implement next generation ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... that could offer a new pathway to restoring vision ... cells in the eye to be light sensitive that ... a gene for a light-sensitive protein into "inner retinal ... that resembles the defect in such inherited human disorders ...
... new 60 and 60 is the new 50, unfortunately for ... it simply isn't true. , New research however from The ... non-pharmaceutical means to maintain muscle function and quality of life ... be as simple as taking a stroll followed by a ...
... Institute, a private laboratory affiliated with the University of Wisconsin-Madison, ... of animal cells and used it to derived two new ... is reported today (Jan. 1, 2006) in the journal Nature ... clinical reality by completely ridding the culture medium in which ...
Cached Biology News:'Prosthetic' retinal cells let blind mice see light 2Chocolate milk could be key to longer, healthier life 2Wisconsin scientists grow two new stem cell lines in animal cell-free culture 2Wisconsin scientists grow two new stem cell lines in animal cell-free culture 3
(Date:2/27/2015)... 2015  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage ... today announced that it will be presenting at CALBIO ... 2 nd at 3pm PST. Patrick Lucy, chief business ... the current state of the biosimilar industry landscape entitled ... For more information on CALBIO 2015 and ...
(Date:2/27/2015)... San Francisco, CA (PRWEB) February 27, 2015 ... is joining forces on February 28 with patients and ... to raise awareness for Rare Disease Day®. Rare ... rare diseases and calling attention to the special challenges ... community around them. , “Cytokinetics is proud to stand ...
(Date:2/27/2015)... Feb. 27, 2015   PureTech , a science ... commercializing disruptive products and technologies in the healthcare sector, ... former CEO and Member of the Board of Directors ... "It,s has been a pleasure to know Chris ... we will be working together more closely now," said ...
(Date:2/26/2015)... 26, 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a ... Genewiz Inc. in excess of $10 million. The jury ... secrets, and that it improperly hired one or more ... motions for judgment notwithstanding the verdict, a new trial, ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... , ATLANTA, Oct. 27 Craneware ... improvement solutions for U.S. healthcare, today announced a presentation ... Strategies Conference scheduled for November 5-7 in Chicago, IL. ... with more than 30 years experience - Director of ...
... Md., Oct. 27 Precision Antibody(TM) has ... of the National Cancer Institute (NCI),s Clinical Proteomic Technologies ... number and standardizing the quality of monoclonal antibody reagents ... is the result of a third solicitation for contract ...
... Switzerland, Oct. 27 Syngenta Ventures announced today that ... privately-held U.S. biotechnology company focused on the use of ... direct investment by Syngenta Ventures, Syngenta,s newly-established corporate venture ... complement our in-house R&D work and enables us to ...
Cached Biology Technology:Hospitals Improve Financial Performance by Identifying Exceptions to Best Practices 2Hospitals Improve Financial Performance by Identifying Exceptions to Best Practices 3Precision Antibody Wins Contract to Develop 'Gold Standard' Antibodies as Part of National Cancer Institute's Clinical Proteomics Technologies for Cancer (CPTC) Initiative 2Precision Antibody Wins Contract to Develop 'Gold Standard' Antibodies as Part of National Cancer Institute's Clinical Proteomics Technologies for Cancer (CPTC) Initiative 3Syngenta Ventures Invests in U.S. Biotech Company Metabolon 2Syngenta Ventures Invests in U.S. Biotech Company Metabolon 3
... Protein Phosphatase-2A (PPase-2A) is a serine/threonine ... It is isolated as the heterodimer of ... has the ability to dephosphorylate the a-subunit ... subunit, PPase-2A has broad substrate specificity and ...
... is a high performance spectral scanning ... incubator. With the advanced SkanIt Software ... for drug discovery assay development. Varioskan ... intensity, time-resolved fluorescence and photometric assays ...
... wide variety of solvent vapors that can contaminate and ... allows for the collection of liquid into a self ... waiting period., Ultra low -104 o C ... , Digital Display of temperature ...
Immulon 2HB, Flat Bottom, 50/Bx; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
Biology Products: